Actively Recruiting
Impact of Virtual Reality (VR) Based Exercises on Lower Limb Lymphedema Outcomes (LELO)
Led by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital · Updated on 2026-03-16
40
Participants Needed
2
Research Sites
56 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This randomized controlled study aims to investigate the effects of virtual reality (VR)-assisted gait training, in addition to Complex Decongestive Therapy (CDT), on gait parameters, physical function, quality of life, and edema levels in patients with lower extremity lymphedema. Lymphedema is a progressive condition characterized by the accumulation of protein-rich fluid due to lymphatic drainage insufficiency, leading to chronic inflammation and fibrosis. It impairs gait patterns and reduces functional mobility. VR technologies, such as the RehaWalk system, provide interactive, personalized rehabilitation environments that enhance motor learning, motivation, and adherence to treatment. The study evaluates spatiotemporal gait parameters, three-zone foot analysis (heel, midfoot, forefoot), limb circumferences, ultrasound measurements (dermis, epidermis, subcutaneous fat thickness), and patient-reported outcomes. VR-based training offers a novel, engaging approach to improve physical rehabilitation outcomes in patients with lower limb lymphedema. No significant risks are expected in this study.
CONDITIONS
Official Title
Impact of Virtual Reality (VR) Based Exercises on Lower Limb Lymphedema Outcomes (LELO)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 65 years
- Diagnosis of unilateral lower extremity lymphedema following gynecological and/or oncological surgery
- Stage 2 or 3 lymphedema
You will not qualify if you...
- Decompensated heart, lung, or kidney failure
- Uncontrolled hypertension
- Presence of systemic infection
- Local infections in the lower extremity such as erysipelas or cellulitis
- Venous insufficiency (e.g., deep vein thrombosis)
- Any neuromuscular or orthopedic disease affecting lower extremity walking
- Presence of balance disorders
- Bilateral lymphedema
- Presence of lipolymphedema
- Fracture in the lower extremity
- Active metastasis
- Speech or language problems
- Pregnancy
- Inability to continue treatment (5 days a week for a total of 4 weeks)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Ankara Gaziler physical therapy and rehabilitationhospital
Ankara, Turkey (Türkiye), 06680
Actively Recruiting
2
Gaziler physical therapy and rehabilitation
Ankara, Turkey (Türkiye)
Actively Recruiting
Research Team
S
SEFA GÜMRÜK ASLAN
CONTACT
S
sefa gümrük aslan, M.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here